The past few years of the pandemic have caused Healthcare Systems to become overburdened all over the world. It is no longer an option but a pressing necessity for countries to make advancements in technology and science and foster collaborations to improve the accessibility and efficiency of healthcare. With challenge comes innovation – the pandemic years saw more Health Science innovations being developed.
Topics: AI / Machine Learning / Deep Learning, MedTech / HealthTech / BioTech
Industry: Health and BioMedical Sciences
Precision medicine aims to find the best, personalised treatment for diseases. It includes health approaches that can better predict, prevent, treat, and manage the disease outside hospitals, such as disease prevention and health promotion activities.
Topics: AI / Machine Learning / Deep Learning, MedTech / HealthTech / BioTech
Industry: Health and BioMedical Sciences
In the information era, we generate tons of data every second: emails, images, videos, sound, metadata. Storing all this information requires extensive data centres and huge costs in infrastructure and maintenance. However, Nature has figured out how to store and process large amounts of data billions of years ago: store them in DNA. Could we do the same and use DNA for long- and short-term storage of our valuable information?
Topics: AI / Machine Learning / Deep Learning, MedTech / HealthTech / BioTech
Industry: Health and BioMedical Sciences
In April 2016, the Singapore Ministry of Health (MOH) declared War on Diabetes to rally a whole-of-nation effort to reduce the diabetes burden in the population. According to MOH, we can expect one in two Singaporeans aged 70 to suffer from Type 2 diabetes by 2050; that's one million people of our population. The cost of diabetes treatment is increasing at double-digit rates throughout Asia. In Singapore alone, over S$1 billion is spent each year managing diabetes - a cost that digital healthcare technology aims to reduce.
Topics: MedTech / HealthTech / BioTech, Deep Tech for Good
Industry: Health and BioMedical Sciences
Biotech as an investment is quite rightly seen as risky because large amounts of capital need to be expended to progress programmes through clinical trials and data readouts, which are highly uncertain and often binary success or fail moments in a company’s evolution.
Investments in BioTech hit an all-time low in the 2000s. This period that lasted more than a decade was known unofficially as the BioTech bust when many therapeutics and diagnostics companies went out of business, and numerous high-quality ideas were starved of funding. But in recent years, the BioTech industry has been going through a period of fast growth - more than USD 10 billion in funding in just the first quarter of 2021, according to CB Insights.
To uncover whether the current BioTech investment boom will last, join our panel of expert leaders as they look to discuss the current BioTech landscape, their take on this boom in BioTech investments, and their outlook on what it takes to make this boom last.
Topics: MedTech / HealthTech / BioTech, Investments
Industry: Health and BioMedical Sciences
There is a common misconception that startup founders are fresh graduates in their early or mid-20s, embarking on a new idea with unencumbered enthusiasm. In reality, the most successful startups are founded by people with established career and industry experience, who have identified a market opportunity based on that experience. A study showed that for the highest-performing startups, the founder was, on average, 45 years old.
Topics: MedTech / HealthTech / BioTech, Startup and Corporate Open Innovation
Industry: Health and BioMedical Sciences
As the world grapples with an ageing population and high incidences of chronic diseases, the gaps in healthcare have prominently surfaced. While innovation, technology and data-driven approaches can improve health outcomes, such an approach often involves a massive amount of confidential data transactions (i.e. patient information) - a lucrative target for hackers and cybercriminals. Healthcare is the most targeted industry for data breaches.
In this session, join our panel of experts to discuss how a data-driven approach can bring us closer to a more transparent and sustainable healthcare system, reduce healthcare costs, and promote better collaboration in the healthcare ecosystem. They will also discuss the challenges in securing health data, data sharing and the role of cybersecurity in designing the healthcare system's networks.
Date: 5 Aug 2021, Thursday
Time: 11:00am – 12:00pm (Singapore Time / UTC +8)
Topics: MedTech / HealthTech / BioTech, Computer Science, Deep Tech for Good
Industry: Health and BioMedical Sciences
In recent years, there has been increasing emphasis on the importance of mental health. Depression is one of the leading causes of disability, and suicide is the second leading cause of death among 15 to 29 year-olds. People with severe mental health conditions die prematurely as much as two decades early due to preventable conditions.
Topics: MedTech / HealthTech / BioTech
Industry: Health and BioMedical Sciences
Morning Pitch is a pitching platform hosted by Deloitte Tohmatsu Venture Support. This platform helps startups form business alliances and partnerships with large corporations, corporate venture capitals and venture capital firms. The focus for this Morning Pitch is on healthcare.
Topics: MedTech / HealthTech / BioTech, Startup and Corporate Open Innovation
Industry: Health and BioMedical Sciences
Here in Singapore, we love our food, and we cannot lie. With many dishes and flavours from all corners of the world, it’s no wonder eating is the (unofficial) Singapore’s favourite pastime. As we continue to enjoy the latest food trends and culinary recipes, it’s essential that we not ignore the growing concern over our food supply.
Topics: MedTech / HealthTech / BioTech, Deep Tech for Good, Sustainability
Industry: AgriFood
We have entered a new era where Artificial Intelligence (AI) enhances human decisions. Every industry is going through a significant transformation - the food industry is no different. Food innovation, mainly in flavour and ingredient innovation, which previously required significant manual research, can be accelerated much more efficiently with the help and proper use of Artificial Intelligence.
Topics: AI / Machine Learning / Deep Learning, MedTech / HealthTech / BioTech, Sustainability
Industry: AgriFood
Since the 1920s, scientists have been pondering why cancer cells do not metabolise sugar in the same way in which healthy cells do. A possible answer may have been found in a recent study by MIT biologists.
Topics: MedTech / HealthTech / BioTech
Industry: Health and BioMedical Sciences